Answers are grounded in this paper and cite their sources.
Background Combined with home‐monitoring, subcutaneous vedolizumab has the potential to promote effective and individualized management in inflammatory bowel diseases (IBDs), as it enables self‐administration and optimizes the use of medical resources. Our study aims to evaluate the feasibility of home‐monitoring based on patient‐reported outcomes (PROs) and fecal calprotectin in patients with IBD treated with subcutaneous vedolizumab. Methods This was an observational study of 43 IBD patients diagnosed with Ulcerative colitis (UC) or Crohn's Disease (CD) at North Zealand Hospital in Denmark. Patients were switched from intravenous to subcutaneous vedolizumab from 2020 to 2022 and followed for 2 years via home‐monitoring app; Constant Care (CC). Data retrieved from https://ibd.constant‐care.com/ including Simple Clinical Colitis Activity Index for UC and Harvey–Bradshaw Index for CD, medicine adherence score, quality of life, and fecal calprotectin (using a home testing kit, CalproSmart). Data, including patient descriptions, drug frequency in weeks, IBD‐related hospital admissions, surgeries, and death, were obtained from patient journals (EPIC system). Results After the exclusion of two patients, 41 patients, CD ( n = 21) and UC ( n = 20) were switched from intravenous to subcutaneous vedolizumab and followed with CC, with high compliance rates to telemonitoring at year 2 (CD 100%, UC 90%). Treatment was evaluated at baseline, after 1 year, and 2 years. At year 2, 18 patients (43.9%) maintained remission with tendency to shortened treatment interval, of which 6 patients stopped treatment due to remission. Twenty patients (48.8%) discontinued, of which 11 patients (55%) due to adverse events. Conclusion Home monitoring has the potential to transform IBD care by delivering real time, long‐term data on patient‐reported outcomes and provides insight into patient‐centered IBD care.
No takes yet. Share an insight, caveat, or question.
Al‐Sheikh et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: